Carol Nishikubo is an Oncology physician affiliated with Saint John's Health Center. OpenAlex indexes 8 publications with 623 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2001 Santa Monica Blvd Ste 560w
Santa Monica, CA 904042182
Telephone
310-453-5654Provider last certified this registry record 23 Jan 2024.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HISTOSONICS, INC.Program year20251 payment
- PFIZER INC.Program year20251 payment
- Aimmune Therapeutics, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
63.6%RANK Ligand Inhibitor63%Denosumab100%Part B, office-administered≥43 patientsBisphosphonate0.5%Zoledronic acid100%Part B, office-administered≥19 patients+ 1 more class in this area
Metabolism & gastrointestinal
31.7%Substance P/Neurokinin-1 Receptor Antagonist28.6%Aprepitant100%Part B, office-administered≥13 patientsSerotonin-3 Receptor Antagonist3.1%Palonosetron hcl100%Part B, office-administered≥21 patientsSensory organs
2.9%Corticosteroid2.9%Dexamethasone sodium phosphate100%Part B, office-administered≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1999–2001 per NIH RePORTER. The latest:
- STEM CELL TRANSPLANTATION FOLLOWED BY RANDOMIZATION TO INTERLEUKIN 2
University of California Los Angeles
FY2001$207,266M01RR000865 - STEM CELL TRANSPLANTATION FOLLOWED BY RANDOMIZATION TO INTERLEUKIN 2
University of California Los Angeles
FY2001$207,266M01RR000865 - STEM CELL TRANSPLANTATION FOLLOWED BY RANDOMIZATION TO INTERLEUKIN 2
University of California Los Angeles
FY1999M01RR000865
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Essner, MD
Saint John's Health Center
Jennifer Linehan, MD
Saint John's Health Center
Dean Nora, MD
Saint John's Health Center
William Katkov, MD
Saint John's Health Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”